Oncolytic Biotechnology


Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.


 

    Related Conference of Oncolytic Biotechnology

    October 24-25, 2024

    8th International Conference on Protein Engineering

    Zurich, Switzerland
    October 24-25, 2024

    28th Global Congress on Biotechnology

    Zurich, Switzerland
    June 23-24, 2025

    28th European Biotechnology Congress

    Aix-en-Provence, France

    Oncolytic Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in